|
EP1816460A1
|
|
Method of performing a denaturing immunassay
|
|
EP1650311A1
|
|
Compounds and methods for assessment of Microsatellite Instability (MSI) status
|
|
EP1628135A1
|
|
Method for detecting medically relevant conditions in a solubilized LBC sample
|
|
EP1510820A1
|
|
Method for detecting medically relevant conditions in a solubilized LBC sample
|
|
US7306926B2
|
|
Method for detecting carcinomas in a solubilized cervical body sample
|
|
EP1507148A1
|
|
Method for detecting carcinomas in a solubilized cervical body sample
|
|
WO2004013631A2
|
|
Compositions and methods for diagnosis and therapy of cancer
|
|
AU2003268905A8
|
|
G - protein coupled receptor marker molecules associated with colorectal lesions
|
|
AU2003232485A1
|
|
Neopeptides and methods useful for detection and treatment of cancer
|
|
EP1422526A1
|
|
Method for improved diagnosis of dysplasias
|
|
US7358060B2
|
|
Method for monitoring and prognosis of disease course of gastrointestinal tumors
|
|
EP1426442A1
|
|
Marker molecules associated with colorectal lesions
|
|
EP1416278A1
|
|
Method for improved diagnosis of dysplasias
|
|
EP1388734A1
|
|
Method for solution based diagnosis
|
|
EP1386929A1
|
|
Peptides associated with tumors and uses related thereto
|
|
EP1387173A1
|
|
Method for improved diagnosis of cervical lesions based on detection of INK4a gene products
|
|
EP1365242A1
|
|
Compounds for detection and treatment of colorectal lesions
|
|
EP1365030A1
|
|
G-protein coupled receptor marker molecules associated with colorectal lesions
|
|
EP1365032A1
|
|
Marker molecules associated with lung tumors
|
|
EP1365031A1
|
|
Method for detection of somatic mutations using mass spectometry
|
